Created at	Source	Raw Value	Validated value
April 7, 2022, 9:30 p.m.	usa	Geometric mean increase (GMI) of SARS-CoV-2 neutralising antibodies;Geometric mean increase (GMI) of SARS-CoV-2 specific IgG binding antibodies.;Geometric mean titer (GMT) of SARS-CoV-2 neutralising antibody;Geometric mean titer (GMT) of SARS-CoV-2 specific IgG binding antibodies.;Proportion of participants achieving seroconversion for SARS-CoV-2 neutralising antibody;Proportion of participants achieving seroconversion for SARS-CoV-2 specific IgG binding antibodies..	Geometric mean increase (GMI) of SARS-CoV-2 neutralising antibodies;Geometric mean increase (GMI) of SARS-CoV-2 specific IgG binding antibodies.;Geometric mean titer (GMT) of SARS-CoV-2 neutralising antibody;Geometric mean titer (GMT) of SARS-CoV-2 specific IgG binding antibodies.;Proportion of participants achieving seroconversion for SARS-CoV-2 neutralising antibody;Proportion of participants achieving seroconversion for SARS-CoV-2 specific IgG binding antibodies..